• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在越南队列中识别结直肠癌的粪便微生物群特征。

Identifying fecal microbiota signatures of colorectal cancer in a Vietnamese cohort.

作者信息

Nhung Pham Thi Tuyet, Le Hang Thi Thu, Nguyen Quang Huy, Huyen Dao Thi, Quyen Dong Van, Song Le Huu, Van Thuan Tran, Tran Tam Thi Thanh

机构信息

Hanoi Medical University, Hanoi, Vietnam.

108 Military Central Hospital, Hanoi, Vietnam.

出版信息

Front Microbiol. 2024 Dec 24;15:1388740. doi: 10.3389/fmicb.2024.1388740. eCollection 2024.

DOI:10.3389/fmicb.2024.1388740
PMID:39777151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11704495/
Abstract

BACKGROUND

Colorectal cancer (CRC) is among the top three causes of global cancer mortality. In Vietnam, CRC is the third leading cause of death in women and the fourth cause of cancer mortality in men. A large number of metagenomic studies have reported the relationship between altered composition and function of the gut microbiota with CRC, but this relationship in low- and middle-income countries including Vietnam (with an estimated population of 100.3 million people in 2023, ranking 16th largest country by population in the world) is not well-explored.

METHODS

We collected clinical data and fecal samples from 43 CRC patients and 44 healthy control subjects. The total community DNA of microorganisms was extracted from the fecal samples and analyzed for microbiota composition using Illumina MiSeq amplicon sequencing targeting the V3-V4 region of the 16S rRNA gene.

RESULTS

We identified a significant difference in the overall fecal microbiota composition between CRC patients and healthy controls, and we detected several CRC-associated microbial signatures in fecal samples of Vietnamese patients with CRC, which overlapped with signatures from other countries and meta-analyses. Although patients with ( = 8) and without ( = 35) type 2 diabetes (T2D) exhibited distinct gut microbiota composition compared to healthy controls, increased relative abundances of putatively pathogenic species including , and were consistent biomarkers for CRC. In contrast, several health-associated species were significantly depleted in CRC patients such as and in CRC/non-T2D patients, pecies, , and in CRC/T2D patients, and in both CRC groups combined.

CONCLUSION

Our findings confirm alterations in gut microbiota composition in CRC in a pilot Vietnamese cohort and highlight several gut microbial taxa that may have inhibitory or driver roles in CRC. This and future studies will enable the development of cancer diagnostics and treatment strategies for CRC in Vietnam, with a focus on targeting the microbiota.

摘要

背景

结直肠癌(CRC)是全球癌症死亡的三大主要原因之一。在越南,CRC是女性死亡的第三大主要原因,是男性癌症死亡的第四大原因。大量宏基因组学研究报告了肠道微生物群组成和功能改变与CRC之间的关系,但在包括越南在内的低收入和中等收入国家(2023年估计人口为1.003亿,是世界上人口第16多的国家),这种关系尚未得到充分探索。

方法

我们收集了43例CRC患者和44例健康对照者的临床数据和粪便样本。从粪便样本中提取微生物的总群落DNA,并使用针对16S rRNA基因V3-V4区域的Illumina MiSeq扩增子测序分析微生物群组成。

结果

我们发现CRC患者和健康对照者的粪便微生物群总体组成存在显著差异,并且在越南CRC患者的粪便样本中检测到了几种与CRC相关的微生物特征,这些特征与其他国家和荟萃分析的特征重叠。尽管患有(n = 8)和未患有(n = 35)2型糖尿病(T2D)的患者与健康对照者相比表现出不同的肠道微生物群组成,但包括[具体物种1]、[具体物种2]和[具体物种3]在内的假定致病物种相对丰度增加是CRC的一致生物标志物。相比之下,一些与健康相关的物种在CRC患者中显著减少,例如CRC/非T2D患者中的[具体物种4]和[具体物种5],CRC/T2D患者中的[具体物种6]、[具体物种7]和[具体物种8],以及两个CRC组合并后的[具体物种9]。

结论

我们的研究结果证实了越南一个试点队列中CRC患者肠道微生物群组成的改变,并突出了几种可能在CRC中具有抑制或驱动作用的肠道微生物分类群。这项研究以及未来的研究将有助于为越南的CRC开发癌症诊断和治疗策略,重点是针对微生物群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/1632b12bbbc3/fmicb-15-1388740-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/5fe51f9bc4ef/fmicb-15-1388740-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/9a00cdfdda5e/fmicb-15-1388740-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/f6c8a50d406e/fmicb-15-1388740-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/1632b12bbbc3/fmicb-15-1388740-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/5fe51f9bc4ef/fmicb-15-1388740-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/9a00cdfdda5e/fmicb-15-1388740-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/f6c8a50d406e/fmicb-15-1388740-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27cb/11704495/1632b12bbbc3/fmicb-15-1388740-g0004.jpg

相似文献

1
Identifying fecal microbiota signatures of colorectal cancer in a Vietnamese cohort.在越南队列中识别结直肠癌的粪便微生物群特征。
Front Microbiol. 2024 Dec 24;15:1388740. doi: 10.3389/fmicb.2024.1388740. eCollection 2024.
2
Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites.不同阶段和不同部位的结直肠癌患者粪便肠道微生物群的特征
Oncol Lett. 2019 Nov;18(5):4834-4844. doi: 10.3892/ol.2019.10841. Epub 2019 Sep 10.
3
Fecal -- Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor.粪便——结直肠侧向发育型肿瘤无创诊断与预后的生物标志物。
Front Oncol. 2021 May 11;11:661048. doi: 10.3389/fonc.2021.661048. eCollection 2021.
4
Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus.宏基因组学和靶向代谢组学分析揭示了结直肠癌和 2 型糖尿病患者肠道微生物群的不同表型。
Chin Med J (Engl). 2023 Dec 5;136(23):2847-2856. doi: 10.1097/CM9.0000000000002421.
5
Fecal Microbiota and Gut Microbe-Derived Extracellular Vesicles in Colorectal Cancer.结直肠癌中的粪便微生物群和肠道微生物衍生的细胞外囊泡
Front Oncol. 2021 Sep 14;11:650026. doi: 10.3389/fonc.2021.650026. eCollection 2021.
6
Detection of colorectal-cancer-associated bacterial taxa in fecal samples using next-generation sequencing and 19 newly established qPCR assays.使用下一代测序技术和19种新建立的定量聚合酶链反应检测粪便样本中与结直肠癌相关的细菌类群。
Mol Oncol. 2025 Feb;19(2):412-429. doi: 10.1002/1878-0261.13700. Epub 2024 Jul 6.
7
Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.唾液和粪便微生物群:结直肠息肉早期筛查的潜在新生物标志物。
Front Microbiol. 2023 Aug 16;14:1182346. doi: 10.3389/fmicb.2023.1182346. eCollection 2023.
8
Exploring Gut Microbiota in Patients with Colorectal Disease Based on 16S rRNA Gene Amplicon and Shallow Metagenomic Sequencing.基于16S rRNA基因扩增子和浅层宏基因组测序技术探究结直肠疾病患者的肠道微生物群
Front Mol Biosci. 2021 Jul 9;8:703638. doi: 10.3389/fmolb.2021.703638. eCollection 2021.
9
Gut microbial and metabolomics profiles reveal the potential mechanism of fecal microbiota transplantation in modulating the progression of colitis-associated colorectal cancer in mice.肠道微生物和代谢组学特征揭示粪便微生物群移植调节结肠炎相关结直肠癌小鼠进展的潜在机制。
J Transl Med. 2024 Nov 15;22(1):1028. doi: 10.1186/s12967-024-05786-4.
10
Gut Microbiome and colorectal cancer: discovery of bacterial changes with metagenomics application in Turkısh population.肠道微生物组与结直肠癌:在土耳其人群中应用宏基因组学发现细菌变化。
Genes Genomics. 2024 Sep;46(9):1059-1070. doi: 10.1007/s13258-024-01538-2. Epub 2024 Jul 11.

引用本文的文献

1
Genomic and functional characterization of a strain isolated from human gut microbiota.从人类肠道微生物群中分离出的一株菌株的基因组和功能特征
mSystems. 2025 Aug 19;10(8):e0079025. doi: 10.1128/msystems.00790-25. Epub 2025 Jul 9.

本文引用的文献

1
Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development.微生物组混杂因素和定量分析方法对预测结直肠癌发展中微生物靶标的挑战。
Nat Med. 2024 May;30(5):1339-1348. doi: 10.1038/s41591-024-02963-2. Epub 2024 Apr 30.
2
The Effects of on Diseases and Its Potential Applications.关于……对疾病的影响及其潜在应用。 (原文中“on”前面缺少具体内容)
Microorganisms. 2023 Oct 17;11(10):2580. doi: 10.3390/microorganisms11102580.
3
A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria.
一种通过减少 CRC 相关细菌来调节结直肠癌风险的益生菌配方。
Cells. 2023 Apr 25;12(9):1244. doi: 10.3390/cells12091244.
4
Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population.鉴定与泰国人群结直肠癌相关的新型肠道微生物群特征。
Sci Rep. 2023 Apr 24;13(1):6702. doi: 10.1038/s41598-023-33794-9.
5
Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression.微小帕拉普氏菌通过上调 miR-218-5p 激活 Ras/ERK/c-Fos 通路促进结直肠癌细胞的进展。
J Exp Clin Cancer Res. 2023 Jan 10;42(1):13. doi: 10.1186/s13046-022-02572-2.
6
Gut microbiota in the early stage of Crohn's disease has unique characteristics.克罗恩病早期的肠道微生物群具有独特特征。
Gut Pathog. 2022 Dec 14;14(1):46. doi: 10.1186/s13099-022-00521-0.
7
Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients.越南结直肠癌患者的肿瘤微生物组和梭杆菌基因组学。
NPJ Biofilms Microbiomes. 2022 Oct 29;8(1):87. doi: 10.1038/s41522-022-00351-7.
8
Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.拟杆菌中间普雷沃氏菌在人类结直肠癌中的富集及其与核梭杆菌的协同作用对结直肠腺瘤恶变的影响。
J Biomed Sci. 2022 Oct 27;29(1):88. doi: 10.1186/s12929-022-00869-0.
9
Meta-Analysis and Validation of a Colorectal Cancer Risk Prediction Model Using Deep Sequenced Fecal Metagenomes.使用深度测序粪便宏基因组的结直肠癌风险预测模型的Meta分析与验证
Cancers (Basel). 2022 Aug 30;14(17):4214. doi: 10.3390/cancers14174214.
10
Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.基于宏基因组关联分析的结直肠癌粪便微生物标志物研究
Microbiol Spectr. 2022 Aug 31;10(4):e0001322. doi: 10.1128/spectrum.00013-22. Epub 2022 Jun 29.